Baveno VII——门静脉高压共识更新
Baveno VII虚拟研讨会于2021年10月召开,聚焦代偿期肝硬化或代偿期进展性慢性肝病(cACLD)患者的个体化门静脉高压管理。会议围绕9个主题系统复习文献并形成共识声明,包括肝静脉压力梯度测定、无创诊断、病因及非病因治疗、首次失代偿预防、急性出血处理、进一步失代偿预防及内脏静脉血栓等血管疾病诊治。声明按与Baveno VI的关系分为不变、改变和新增三类。
要点
- cACLD定义沿用Baveno VI会议标准,用于识别代偿期进展性慢性肝病患者。
- 临床显著门静脉高压(CSPH)的存在与否与死亡风险及诊疗需求不同相关。
- 共识覆盖肝静脉压力梯度、无创诊断、出血管理及内脏静脉血栓等9个主题。
核心结论
- Baveno VII共识围绕代偿期肝硬化或cACLD患者的个体化门静脉高压管理形成系列推荐,声明按与Baveno VI关系分为不变、改变和新增三类。
研究设计与样本
- Baveno VII虚拟研讨会于2021年10月召开,针对9个主题系统复习医学文献并讨论形成共识声明。
主要发现
- 代偿期肝硬化或cACLD患者中,CSPH的存在与否与包括死亡风险在内的不同结局及不同诊断治疗需求相关。
- 讨论主题涵盖肝静脉压力梯度作为金标准的指征、cACLD与CSPH的无创诊断工具、病因及非病因治疗对肝硬化病程的影响。
- 讨论主题还包括首次失代偿预防、急性出血发作管理、进一步失代偿预防以及内脏静脉血栓和其他肝脏血管疾病的诊断与管理。
关键数值与推荐
- cACLD沿用Baveno VI会议的定义。
- 共识声明按与Baveno VI的关系分类为不变、改变和新增。
临床怎么用
- 原文未据此给出具体推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To expand on the work of previous meetings, a virtual Baveno VII workshop was organised for October 2021. Among patients with compensated cirrhosis or compensated advanced chronic liver disease (cACLD - defined at the Baveno VI conference), the presence or absence of clinically significant portal hypertension (CSPH) is associated with differing outcomes, including risk of death, and different diagnostic and therapeutic needs. Accordingly, the Baveno VII workshop was entitled "Personalized Care for Portal Hypertension". The main fields of discussion were the relevance and indications for measuring the hepatic venous pressure gradient as a gold standard, the use of non-invasive tools for the diagnosis of cACLD and CSPH, the impact of aetiological and non-aetiological therapies on the course of cirrhosis, the prevention of the first episode of decompensation, the management of an acute bleeding episode, the prevention of further decompensation, as well as the diagnosis and management of splanchnic vein thrombosis and other vascular disorders of the liver. For each of these 9 topics, a thorough review of the medical literature was performed, and a series of consensus statements/recommendations were discussed and agreed upon. A summary of the most important conclusions/recommendations derived from the workshop is reported here. The statements are classified as unchanged, changed, and new in relation to Baveno VI.
引用
- de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2021. PMID: 35120736. doi:10.1016/j.jhep.2021.12.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。